This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Index funds track a market index to provide diversified exposure at low costs. This primer covers structure and how beginners can start investing.
13,072 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
In a move that stirs controversy, a $1.7 billion fund is being created to compensate allies in a settlement tied to T...
A mid-sized fund has quietly built a sizable Porch Group position, signaling conviction in this tech-insurance combo....
A large institutional bet on Futu stock sparked headlines as shares fell nearly a quarter. This article breaks down w...
Fidelity's Dividend ETF for Rising Rates has surged 23% over the last year, but the fund’s tech-heavy, rate-sensitive...
Money moments can feel forced and awkward—whether inflation, debt, or family pressure. This guide turns that discomfo...
A major investment fund disclosed a $13.93 million exit from a booming AI investment in Q1 2026. Here’s what this mov...
A major fund recently shed about $20 million worth of Graphic Packaging shares, prompting questions about the company...
When a large manager trims a position, questions follow. This article breaks down Hilton Capital’s $25 million GPIX s...
Choosing between SPGM and IEFA depends on your goals: total-global exposure or a focus on developed markets outside N...
A World Cup finale isn’t just a trophy moment; it’s a family moment that reveals how households can plan for big cele...
A political moment can ripple beyond headlines and affect your wallet. This guide delivers practical, veteran-tested ...